back to US directory
us clinical guidance

Adult first unprovoked seizure: prognosis and treatment decision

AAN/AES evidence on recurrence prognosis and whether to start immediate treatment after an adult first unprovoked seizure.

JurisdictionUnited States
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceUnited States healthcare professionals
This is an iatroX educational summary of named United States sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Use the named authority, current FDA labeling, applicable state law, payer rules and local protocol where relevant.

Scope of this summary

Adults whose event has already been clinically classified as a first unprovoked seizure. The AAN/AES guideline addresses recurrence prognosis and the decision about immediate antiseizure treatment. It does not establish event diagnosis, acute-provocation testing, EEG or imaging timing, medicine selection, rescue treatment, driving rules, pregnancy care or management of established epilepsy syndromes.
sources for this section:AAN/AES first seizure

The Bottom Line

  • The guideline applies only after the event has been classified as an adult first unprovoked seizure; it is not an event-diagnosis algorithm.
  • Recurrence risk is highest during the first two years and is increased by a prior brain insult, epileptiform EEG findings, a significant brain-imaging abnormality or a nocturnal seizure.
  • Immediate antiseizure treatment reduces the chance of another seizure during the next two years but does not improve the longer-term likelihood of sustained seizure remission.
  • The decision to start treatment should be individualized by weighing recurrence risk against adverse effects and the person鈥檚 preferences and consequences of recurrence.
  • The source reports that treatment adverse events occur in a minority of patients and are generally mild and reversible, but it does not choose a specific medicine or monitoring plan.
sources for this section:AAN/AES first seizure

Practical clinical workflow

1
Confirm that a separate diagnostic assessment has already classified the event as unprovoked and that this adult guideline is the relevant source.
2
Identify which of the four source-supported recurrence factors are present without using this page to decide how or when to obtain EEG or imaging.
3
Explain the difference between reducing short-term recurrence and changing long-term sustained remission so the treatment tradeoff is clear.
4
Discuss the individual consequences of another seizure and the possibility of treatment adverse effects, then document the person鈥檚 preferences.
5
If immediate treatment is selected, use a separate current authority and FDA labeling to choose the agent, dose, interactions and monitoring.
sources for this section:AAN/AES first seizure

Safety boundaries and escalation

  • This source does not establish the emergency management of a prolonged or repeated seizure, an acute symptomatic seizure or status epilepticus.
  • It does not supply a laboratory, ECG, imaging, EEG-timing or differential-diagnosis pathway for a possible first event.
  • It does not supply medicine selection, titration, monitoring, rescue-plan, withdrawal or pregnancy-specific recommendations.
  • It does not establish state driving restrictions or clinician-reporting duties; those legal rules must come from the applicable state authority.
sources for this section:AAN/AES first seizure

Localization

The AAN/AES guideline was published in 2015 and reaffirmed in 2024. Its US scope is prognosis and immediate-treatment decision-making after an adult first unprovoked seizure. State motor-vehicle law, acute-care protocols, medicine labeling and established-epilepsy care remain separate.
sources for this section:AAN/AES first seizure

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. American Academy of Neurology and American Epilepsy SocietyManagement of an Unprovoked First Seizure in Adults2015 practice guideline; reaffirmed 2024-02-10 路 published 2015-04-01 路 updated 2024-02-10 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the US question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.